Literature DB >> 14652628

Matricellular proteins as modulators of wound healing and the foreign body response.

Themis R Kyriakides1, Paul Bornstein.   

Abstract

Matricellular proteins form a group of extracellular matrix (ECM) proteins that do not subserve a primary structural role, but rather function as modulators of cell-matrix interactions. Members of the group, including thrombospondin (TSP)-1,TSP-2, SPARC, tenascin (TN)-C, and osteopontin (OPN), have been shown to participate in a number of processes related to tissue repair. Specifically, studies in knockout mice have indicated that a deficiency in one or more of these proteins can alter the course of wound healing. More recently, TSP1, TSP2, and SPARC have also been implicated in the foreign body response, an unusual reaction to injury that occurs after the implantation of biomaterials. This review will focus on the roles of these proteins in the response to injury in mice and will show how studies of this pathophysiological process can elucidate some of the intrinsic properties of these matricellular proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14652628     DOI: 10.1160/TH03-06-0399

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  71 in total

1.  Pre- and post-translational regulation of osteopontin in cancer.

Authors:  Pieter H Anborgh; Jennifer C Mutrie; Alan B Tuck; Ann F Chambers
Journal:  J Cell Commun Signal       Date:  2011-04-26       Impact factor: 5.782

2.  The matrix-binding domain of microfibril-associated glycoprotein-1 targets active connective tissue growth factor to a fibroblast-produced extracellular matrix.

Authors:  Justin S Weinbaum; Robert T Tranquillo; Robert P Mecham
Journal:  Macromol Biosci       Date:  2010-11-10       Impact factor: 4.979

3.  Foreign body giant cell formation is preceded by lamellipodia formation and can be attenuated by inhibition of Rac1 activation.

Authors:  Steven M Jay; Eleni Skokos; Farah Laiwalla; Marie-Marthe Krady; Themis R Kyriakides
Journal:  Am J Pathol       Date:  2007-06-07       Impact factor: 4.307

4.  Functional role of periostin in development and wound repair: implications for connective tissue disease.

Authors:  Douglas W Hamilton
Journal:  J Cell Commun Signal       Date:  2008-07-20       Impact factor: 5.782

Review 5.  Matricellular proteins and biomaterials.

Authors:  Aaron H Morris; Themis R Kyriakides
Journal:  Matrix Biol       Date:  2014-03-20       Impact factor: 11.583

Review 6.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

7.  Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis.

Authors:  Yong Wook Park; Young Mo Kang; Joe Butterfield; Michael Detmar; Jörg J Goronzy; Cornelia M Weyand
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Dual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healing.

Authors:  François Maquerlot; Stephane Galiacy; Michel Malo; Christophe Guignabert; Daniel A Lawrence; Maria-Pia d'Ortho; Georgia Barlovatz-Meimon
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

9.  Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9.

Authors:  Susan MacLauchlan; Eleni A Skokos; Norman Meznarich; Dana H Zhu; Sana Raoof; J Michael Shipley; Robert M Senior; Paul Bornstein; Themis R Kyriakides
Journal:  J Leukoc Biol       Date:  2009-01-13       Impact factor: 4.962

10.  Differential Expression of SPARC in Intestinal-type Gastric Cancer Correlates with Tumor Progression and Nodal Spread.

Authors:  Konrad Franke; Stacy Carl-McGrath; Friedrich-Wilhelm Röhl; Uwe Lendeckel; Matthias Pa Ebert; Marc Tänzer; Matthias Pross; Christoph Röcken
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.